The Trump administration issued a final rule banning Medicaid and CHIP from covering puberty blockers, cross-sex hormones, and surgeries for minors, a move LGBTQ+ advocates have vowed to challenge in court.
HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz announced the policy on Tuesday, cutting off federal dollars for gender transition procedures performed on children. The rule, which takes effect October 13, applies to both Medicaid and the Children's Health Insurance Program, which together cover tens of millions of American minors. Mental health services remain covered.
Kennedy framed the decision in blunt terms. "Today, we are ending federal taxpayer funding for sex-rejecting procedures on children," he said in an official statement, as Breitbart reported. "These interventions carry serious risks and can cause irreversible harm. The federal government will no longer use Medicaid and CHIP dollars to fund procedures that fail to meet the evidentiary standard our children deserve."
The rule covers three categories of treatment: puberty-suppressing drugs, cross-sex hormones, and surgical interventions. Children currently receiving hormone therapy through Medicaid or CHIP will have a tapering-off period of up to six months, with AP News reporting the phase-out running through April 2027 for those already in treatment.
CMS said the rule rests on a review of national and international research that found "significant evidence gaps and serious safety concerns." The agency cited risks including infertility, impaired sexual function, diminished bone density, and altered brain development, effects it described as potentially irreversible.
The financial scope of the federal government's involvement came into sharper focus through reporting by the Washington Examiner. CMS spent $30 million in Medicaid payments in 2023 alone on gender transition treatments for minors, with a projected $250 million tab over the next decade if the spending had continued unchecked.
That figure raises a straightforward question for taxpayers: why was the federal government funding procedures its own agency now concedes lack "sufficiently reliable evidence of clinical benefit"?
Dr. Oz put it plainly in his official statement:
"Children deserve our protection, not experimental interventions that pose serious risks and convey no proven benefits. By cutting off federal funds for these sex-rejecting procedures, we're following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish."
The administration's broader crackdown on Medicaid waste and abuse has extended well beyond this single rule. Vice President Vance has put blue-state officials on notice over a billion-dollar Medicaid fraud crackdown that could carry prison time for those responsible.
Kennedy went further in a separate statement reported by the Washington Examiner, declaring that gender transition procedures for minors "do not meet professionally recognized standards of care." He described the financial incentives driving the industry in stark terms:
"Hospitals rake in millions of dollars by convincing boys and girls that a lifetime of off-label prescriptions for estrogen and testosterone blockers, chest reconstruction, surgeries, and more are the only way to achieve true happiness and belonging in life. It's wrong."
CMS pointed to mounting international evidence as a foundation for the rule. The agency cited the United Kingdom's Cass Review, a landmark independent report that found research on medical interventions for gender-questioning minors was limited and not definitive. Fox News noted the Cass Review served as a key piece of supporting research behind the decision.
Sweden has also moved to restrict gender transition procedures for minors, and the Society of Plastic Surgeons has shifted its own policies on the issue. CMS said the administration's assessment is "increasingly reflected" within the medical community itself, a notable concession from professional organizations that had previously endorsed these treatments.
The pattern is consistent across multiple countries: governments that initially embraced medical gender transition for children are now pulling back as long-term data raises red flags about safety and efficacy. The United States, under this rule, joins that international trend rather than continuing to lag behind it.
Kennedy and Oz have also turned their attention to broader integrity problems in federal health programs. The pair recently revealed that over one million Obamacare enrollees have no Social Security number on file, another example of taxpayer-funded health programs operating without basic accountability checks.
President Trump endorsed the decision in a Truth Social post, saying he had personally directed Oz to make the announcement. Trump wrote that Medicaid "will NO LONGER fund gender transition surgeries and hormones for minors" and credited his administration's sustained pressure over the past year and a half with prompting dozens of hospitals to end the procedures voluntarily.
"Thanks to our strong position and pressure on this issue over the past year and a half, dozens of U.S. hospitals have already ended this so-called 'gender-affirming care,' and we expect many more to follow," Trump wrote.
He also pointed to the upcoming midterm elections, urging voters to remember the issue at the ballot box. "While the [Democrat] Party wants your kids to be able to chop off their reproductive organs before they are old enough to vote, President Donald J. Trump (ME!) and the Republican Party say that is ABSURD, and we will protect America's children," he wrote.
The Department of Justice has already taken enforcement action on a related front, reaching an agreement with Connecticut Children's Medical Center over gender transition drugs for minors, one of several institutional steps that preceded the broader Medicaid rule.
This enforcement posture mirrors the administration's approach across federal spending, where officials have identified a clear pattern of fraud in federal programs and moved aggressively to shut down waste.
The response from progressive advocacy organizations was immediate. Human Rights Campaign President Kelley Robinson condemned the rule in terms that AP News reported:
"The Trump administration is terrorizing trans youth and their families with these kinds of actions, and it has to stop."
LGBTQ+ advocates have vowed to mount legal challenges against the rule. Democrats and allied groups argue the policy represents federal overreach into medical practice, a framing that sets up a likely courtroom battle over whether CMS has the authority to exclude specific categories of treatment from Medicaid coverage.
But the administration's position draws strength from the very research that gender-medicine advocates once insisted supported their case. When the Cass Review, commissioned by Britain's National Health Service, not by American conservatives, concluded the evidence base was thin and unreliable, it undercut the central claim that these procedures represent established, evidence-based medicine.
The political fallout from the broader debate over children's health programs has already begun to show up in state-level polls. Minnesota Governor Tim Walz, who championed progressive policies on youth gender medicine, has seen his approval rating drop to an all-time low as fraud-related controversies deepen.
The proposed rule carries the formal designation CMS-2451, titled "Medicaid Program; Prohibition on Federal Medicaid Funding for Sex Trait Modification Procedures Furnished to Children and Youth." National Review reported that HHS filed the proposed rule following its own exclusive reporting on the issue, and the regulation moved through White House regulatory review before reaching its final form.
The rule takes effect October 13. After that date, no federal Medicaid or CHIP dollar will pay for puberty blockers, cross-sex hormones, or surgeries aimed at gender transition for anyone under the age of eligibility. Mental health services remain fully covered.
For years, taxpayers were told these procedures were settled science and that questioning them was bigotry. Now the federal government's own research review says the evidence was never there, and the people who pushed hardest to fund these treatments on children are the ones who owe an explanation.